rs755097302
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001384732.1(CPLANE1):βc.1270C>Tβ(p.Arg424*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,551,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001384732.1 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPLANE1 | NM_001384732.1 | c.1270C>T | p.Arg424* | stop_gained | 10/53 | ENST00000651892.2 | NP_001371661.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPLANE1 | ENST00000651892.2 | c.1270C>T | p.Arg424* | stop_gained | 10/53 | NM_001384732.1 | ENSP00000498265.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 5AN: 156676Hom.: 0 AF XY: 0.0000482 AC XY: 4AN XY: 82996
GnomAD4 exome AF: 0.0000314 AC: 44AN: 1399222Hom.: 0 Cov.: 32 AF XY: 0.0000319 AC XY: 22AN XY: 690108
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74292
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 16, 2017 | The R424X variant in the C5orf42 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R424X variant was not observed in approximately 2300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R424X as a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 15, 2017 | This sequence change creates a premature translational stop signal (p.Arg424*) in the C5orf42 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs755097302, ExAC 0.03%). This variant has not been reported in the literature in individuals with C5orf42-related disease. ClinVar contains an entry for this variant (Variation ID: 392297). Loss-of-function variants in C5orf42 are known to be pathogenic (PMID: 22425360). For these reasons, this variant has been classified as Pathogenic. - |
Orofaciodigital syndrome type 6;C3553264:Joubert syndrome 17 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 19, 2021 | - - |
Joubert syndrome 17 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 24, 2021 | - - |
Joubert syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Neurology, Linyi Peopleβs Hospital, The Eleventh Clinical Medical College of Qingdao University | Jan 02, 2021 | The nonsense variant c.1270C>T (p.Arg424*) in exon 10 resulted in the 2120th base with the change from C to T in the coding region of CPLANE1 , which caused substitution from arginine to a stop codon at the 424th amino acid of the encoded protein, and may cause protein truncation or activate degradation of the mRNA of CPLANE1 via nonsense mediation, thereby affecting the function of the protein product encoded by CPLANE1 (PVS1). This variant is present in population databases (rs755097302, ExAC 0.03%), and the frequency is G = 0.0001 (PM2). It has not been reported in the literature in individuals, but the ClinVar database contains an entry for this mutation as a "pathogenic variant" (variation ID: 392297) for Oral-facial-digital syndrome VI and Joubert syndrome 17 (PM3_Strong). The father of the proband carries a heterozygous mutation at this locus. According to the available evidence, it is defined as the pathogenic variant (PVS1+PM3_Strong+PM2) based on the 2015 ACMG guidelines. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at